세계의 인간 및 동물 건강용 감염 관리 시장 : 제품 유형별(소독 제품, 개인보호구, 멸균 장비), 감염 유형별, 최종사용자별 예측(-2032년)
Global Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products, Personal Protective Equipment, and Sterilization Equipment ), by Infection Type, by End Us - Forecast to 2032
인간 및 동물 건강용 감염 관리 시장 규모는 2023년 95억 6,000만 달러에서 예측 기간 동안 8.16%의 CAGR을 기록하며 2032년에는 209억 5,000만 달러 규모로 성장할 것으로 예상됩니다.
감염병의 유행은 인간 및 동물 건강용 감염 관리 시장의 주요 촉진요인입니다. 최근 몇 년 동안 전 세계적으로 많은 전염병의 발생 빈도가 눈에 띄게 증가하여 감염 관리 제품 및 방법에 대한 수요가 증가하고 있습니다.
감염 관리 기술에 대한 인식의 증가는 인간 및 동물 건강 시장의 주요 촉진요인입니다. 최근 몇 년간의 전염병과 세계 건강 위기로 인해 감염 예방의 필요성에 대한 시민과 전문가들의 인식이 높아졌습니다. 언론 보도 증가, 교육 캠페인, 정부 정책 등은 모두 시민과 의료계의 지식 향상에 기여하고 있습니다. 개인과 의료 전문가 모두 감염병 확산 방지를 위한 소독 제품, 개인보호장비(PPE), 멸균 장비의 필요성을 인식하고 있습니다. 병원, 진료소, 공공시설 등 많은 곳에서 감염 관리의 중요성이 강조되면서 혁신적이고 효과적인 감염 관리 시스템에 대한 수요가 증가하고 있습니다.
지역별 인사이트
북미는 2022년 33.75% 이상의 점유율로 가장 큰 비중을 차지했습니다. 이는 이 지역의 높은 의료 인프라, 엄격한 규제, 감염 관리에 대한 높은 인식, 수술 건수의 증가로 인해 PPE는 정형외과 수술에서 환자와 의료진 모두의 감염을 예방하기 위해 많이 사용되고 있습니다.
유럽의 인간 및 동물 건강용 감염 관리 시장은 유럽 전역의 감염 사례 증가로 인해 예측 기간 동안 크게 확대될 것으로 예상됩니다.
아시아태평양은 활기차고 다양한 시장입니다. 인구 증가, 도시화, 의료 관련 표준에 대한 인식이 높아지면서 효과적인 감염 예방 및 관리 전략에 대한 필요성이 증가하고 있습니다.
세계의 인간 및 동물 건강용 감염 관리 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추정 및 예측, 각 부문별·지역별·주요 국가별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 시장 개요
제2장 조사 방법
제3장 시장 역학
- 개요
- 성장 촉진요인
- 감염증 만연 증가
- 감염 관리 대책에 대한 의식 상승
- 성장 억제요인
- 기회
- 기술적으로 진보한 지속가능한 감염 관리 솔루션에 대한 수요 증가
제4장 시장 요인 분석
- 밸류체인 분석
- Porter's Five Forces 분석
- COVID-19가 시장에 미치는 영향
제5장 세계의 인간 및 동물 건강용 감염 관리 시장 : 제품별
- 개요
- 소독 제품
- 액체 소독제
- 소독용 물티슈
- 소독 스프레이
- 기타
- 개인보호장비(PPE)
- 멸균 장비
- 가열 살균 장비
- 저온 살균 장비
- 방사선 멸균 장비
- 여과 멸균 장비
- 기타
제6장 세계의 인간 및 동물 건강용 감염 관리 시장 : 감염 유형별
제7장 세계의 인간 및 동물 건강용 감염 관리 시장 : 최종사용자별
제8장 세계의 인간 및 동물 건강용 감염 관리 시장 : 지역별
제9장 경쟁 상황
- 시장 점유율 분석
- 경쟁 대시보드
- 공개 기업 주식 개요
- 비교 분석 : 주요 기업 재무 데이터
- 주요 전개와 성장 전략
제10장 기업 개요
- 3M
- ZOETIS ANIMAL HEALTHCARE
- PEROTECH SCIENCES INC.
- STERIS PLC
- GETINGE AB
- VIROX TECHNOLOGIES, INC.
- ADVANCED STERILIZATION PRODUCTS
- NEOGEN CORPORATION
- CARDINAL HEALTH
- STRYKER
제11장 데이터 인용
ksm
Global Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us (Human Healthcare Facilities and Animal Healthcare facilities)- Forecast to 2032
Market Overview
The Infection Control for Human and Animal Health Market industry is expected to increase from USD 9.56 billion in 2023 to USD 20.95 billion by 2032, with a compound yearly growth rate (CAGR) of 8.16% over the forecast period (2023-2032).
The rising prevalence of infectious diseases is a major driver of infection control in the human and animal health markets. In recent years, there has been a significant increase in the frequency of numerous infectious diseases around the world, resulting in increased demand for infection control products and methods.
Rising awareness of infection control techniques is a key driver for the human and animal health markets. The recent pandemics and global health crises have heightened public and professional awareness of the necessity of infection prevention. Increased media coverage, educational campaigns, and government measures have all contributed to a better knowledgeable public and healthcare community. Individuals and healthcare professionals alike understand the need of disinfection products, personal protective equipment (PPE), and sterilizing equipment in preventing the spread of infectious diseases. The rising emphasis on infection control practices in many contexts, including hospitals, clinics, and public areas, has resulted in an increase in demand for innovative and effective infection control systems.
Market Segment insights
The Infection Control for Human and Animal Health Market is divided into three product categories: disinfection, personal protective equipment (PPE), and sterilization.
The market has been divided into four types of infections: viral, bacterial, parasitic, and fungal.
The market is divided into two segments based on end users: human healthcare facilities and animal healthcare facilities.
Regional insights
North America had the biggest market share of more than 33.75% in 2022, owing to the region's sophisticated healthcare infrastructure, tight regulations, high awareness of infection control measures, and increasing number of surgical procedures. PPE is often used in orthopedic surgery to avoid infections in both patients and healthcare staff. According to the American Joint Replacement Registry's annual report for 2021, 2,244,587 hip and knee operations were conducted.
Europe's infection control market for human and animal health is expected to rise significantly during the forecast year, 2022-2023, due to an increase in infection cases across Europe. The infection control industry in Europe, which includes both human and animal health, is seeing a significant spike, driven by increased awareness of infectious illnesses and the demand for better preventive measures. According to the World Health Organization, on June 26, 2023, Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland reported an increase in confirmed cases of E-11 infection in neonates and babies, with substantial morbidity and death.
The Asia-Pacific area is a vibrant and diversified market for infection control in human and animal health. With a fast-growing population, more urbanization, and rising awareness of healthcare standards, there is a greater need for effective infection prevention and control strategies. According to the United Nations Population Fund (UNFPA), Asia and the Pacific make up 60% of the world's population, or around 4.3 billion people.
Major Players
Advanced Sterilization Products (US), STERIS plc (Ireland), Getinge AB (Sweden), Virox Technologies, Inc. (Canada), 3M (US), Zoetis Animal Healthcare (US), PeproTech Sciences Inc (Canada), Neogen Corporation (US), Cardinal Health (US), and Stryker (US) are among the key players in the Infection Control for Human and Animal Health Market.
TABLE OF CONTENTS
1 MARKET INTRODUCTION
- 1.1 DEFINITION
- 1.2 SCOPE OF THE STUDY
- 1.3 RESEARCH OBJECTIVE
- 1.4 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
- 2.1 OVERVIEW
- 2.2 DATA FLOW
- 2.2.1 DATA MINING PROCESS
- 2.3 PURCHASED DATABASE:
- 2.4 SECONDARY SOURCES:
- 2.4.1 SECONDARY RESEARCH DATA FLOW:
- 2.5 PRIMARY RESEARCH:
- 2.5.1 PRIMARY RESEARCH DATA FLOW:
- 2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 2.6.1 REVENUE ANALYSIS APPROACH
- 2.7 DATA FORECASTING
- 2.7.1 DATA FORECASTING TECHNIQUE
- 2.8 DATA FORMULATIONLING
- 2.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 2.8.2 DATA FORMULATIONLING:
- 2.9 TEAMS AND ANALYST CONTRIBUTION
3 MARKET DYNAMICS
- 3.1 INTRODUCTION
- 3.2 DRIVERS
- 3.2.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES
- 3.2.2 RISING AWARENESS OF INFECTION CONTROL MEASURES
- 3.3 RESTRAINTS
- 3.3.1 COST CONSTRAINTS IN INFECTION CONTROL
- 3.4 OPPORTUNITY
- 3.4.1 GROWING DEMAND FOR TECHNOLOGICALLY ADVANCED AND SUSTAINABLE INFECTION CONTROL SOLUTIONS
4 MARKET FACTOR ANALYSIS
- 4.1 VALUE CHAIN ANALYSIS
- 4.1.1 R&D
- 4.1.2 MANUFACTURING
- 4.1.3 DISTRIBUTION AND SALES
- 4.1.4 POST-SALES MONITORING
- 4.2 PORTER'S FIVE FORCES MODEL
- 4.2.1 THREAT OF NEW ENTRANTS
- 4.2.2 BARGAINING POWER OF SUPPLIERS
- 4.2.3 THREAT OF SUBSTITUTES
- 4.2.4 BARGAINING POWER OF BUYERS
- 4.2.5 INTENSITY OF RIVALRY
- 4.3 IMPACT OF COVID-19 ON THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
- 4.3.1 IMPACT ON SUPPLY CHAIN
- 4.3.2 IMPACT ON MARKET PLAYERS
5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT
- 5.1 OVERVIEW
- 5.2 DISINFECTION PRODUCTS
- 5.2.1 LIQUID DISINFECTANTS
- 5.2.2 DISINFECTANT WIPES
- 5.2.3 DISINFECTANT SPRAYS
- 5.2.4 OTHERS
- 5.3 PERSONAL PROTECTIVE EQUIPMENT (PPE)
- 5.3.1 GLOVES
- 5.3.2 MASKS
- 5.3.3 GOWNS
- 5.3.4 PROTECTIVE EYEWEAR
- 5.3.5 OTHERS
- 5.4 STERILIZATION EQUIPMENT
- 5.4.1 HEAT STERILIZATION EQUIPMENT
- 5.4.2 LOW-TEMPERATURE STERILIZATION EQUIPMENT
- 5.4.3 RADIATION STERILIZATION EQUIPMENT
- 5.4.4 FILTRATION STERILIZATION EQUIPMENT
- 5.4.5 OTHERS
6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE
- 6.1 OVERVIEW
- 6.2 VIRAL
- 6.3 BACTERIAL
- 6.4 PARASITIC
- 6.5 FUNGAL INFECTIONS
7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER
- 7.1 OVERVIEW
- 7.2 HUMAN HEALTHCARE FACILITIES
- 7.2.1 HOSPITALS & CLINICS
- 7.2.2 AMBULATORY SURGICAL CENTERS
- 7.2.3 OTHERS
- 7.3 ANIMAL HEALTHCARE FACILITIES
- 7.3.1 VETERINARY HOSPITALS
- 7.3.2 ANIMAL SHELTERS
- 7.3.3 FARMING FACILITIES
- 7.3.4 OTHERS
8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION
- 8.1 OVERVIEW
- 8.2 NORTH AMERICA
- 8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
- 8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 AUSTRALIA
- 8.4.5 SOUTH KOREA
- 8.4.6 REST OF ASIA-PACIFIC
- 8.5 REST OF THE WORLD
- 8.5.1 REST OF THE WORLD
- 8.5.2 MIDDLE EAST & AFRICA
- 8.5.3 SOUTH AMERICA
9 COMPETITIVE LANDSCAPE
- 9.1 INTRODUCTION
- 9.2 MARKET SHARE ANALYSIS,
- 9.3 COMPETITOR DASHBOARD
- 9.4 PUBLIC PLAYERS STOCK SUMMARY
- 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
- 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10 COMPANY PROFILE
- 10.1 3M
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
- 10.2 ZOETIS ANIMAL HEALTHCARE
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
- 10.3 PEROTECH SCIENCES INC.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
- 10.4 STERIS PLC
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGY
- 10.5 GETINGE AB
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.5.6 KEY STRATEGY
- 10.6 VIROX TECHNOLOGIES, INC.
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
- 10.7 ADVANCED STERILIZATION PRODUCTS
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 KEY STRATEGIES
- 10.8 NEOGEN CORPORATION
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
- 10.9 CARDINAL HEALTH
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
- 10.10 STRYKER
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES
11 DATA CITATIONS
